AIA Group’s Globus Medical GMED Stock Holding History

AIA Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,789	Closed	-$404K	–	300
2023 Q2	$404K	Buy	+6,789	New	+$387K	0.02%	267

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AIA Group's GMED Position: Q3 2023 in Review

AIA Group sold out of Globus Medical (GMED) in Q3 2023, closing a stake of 6,789 shares — an estimated $404K sold.

AIA Group first reported a position in GMED in Q2 2023 and held it in 1 quarter. The position peaked at $404K in Q2 2023. 431 funds tracked by Wall St. Rank hold GMED as of Q3 2023.

AIA Group reported no remaining Globus Medical position as of Q3 2023 after selling out during the quarter.
AIA Group sold 6,789 Globus Medical shares in Q3 2023, an estimated $404K.
AIA Group first reported a position in Globus Medical in Q2 2023 and held it in 1 quarter.
AIA Group's Globus Medical position peaked at $404K in Q2 2023.
431 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.

Based on AIA Group's 13F filing for Q3 2023, filed 1 Nov 2023.